AAAAAA

   
Results: 1-20 |
Results: 20
In multiple myeloma, only a single stage of neoplastic plasma cell differentiation can be identified by VLA-5 and CD45 expression
Authors: Rawstron, AC Barrans, SL Blythe, D English, A Richards, SJ Fenton, JAL Davies, FE Child, JA Jack, AS Morgan, GJ
Citation: Ac. Rawstron et al., In multiple myeloma, only a single stage of neoplastic plasma cell differentiation can be identified by VLA-5 and CD45 expression, BR J HAEM, 113(3), 2001, pp. 794-802
The impact of attaining a minimal disease state after high-dose melphalan and autologous transplantation for multiple myeloma
Authors: Davies, FE Forsyth, PD Rawstron, AC Owen, RG Pratt, G Evans, PAS Richards, SJ Drayson, M Smith, GM Selby, PJ Child, JA Morgan, GJ
Citation: Fe. Davies et al., The impact of attaining a minimal disease state after high-dose melphalan and autologous transplantation for multiple myeloma, BR J HAEM, 112(3), 2001, pp. 814-819
Insertional events as well as translocations may arise during aberrant immunoglobulin switch recombination in a patient with multiple myeloma
Authors: Pratt, G Fenton, JAL Davies, FE Rawstron, AC Richards, SJ Collins, JE Owen, RG Jack, AS Smith, GM Morgan, GJ
Citation: G. Pratt et al., Insertional events as well as translocations may arise during aberrant immunoglobulin switch recombination in a patient with multiple myeloma, BR J HAEM, 112(2), 2001, pp. 388-391
Interleukin 6, tumour necrosis factor alpha and lymphotoxin polymorphisms in monoclonal gammopathy of uncertain significance and multiple myeloma
Authors: Dring, AM Davies, FE Rollinson, SJ Roddam, PL Rawstron, AC Child, JA Jack, AS Morgan, GJ
Citation: Am. Dring et al., Interleukin 6, tumour necrosis factor alpha and lymphotoxin polymorphisms in monoclonal gammopathy of uncertain significance and multiple myeloma, BR J HAEM, 112(1), 2001, pp. 249-250
Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration
Authors: Podar, K Tai, YT Davies, FE Lentzsch, S Sattler, M Hideshima, T Lin, BK Gupta, D Shima, Y Chauhan, D Mitsiades, C Raje, N Richardson, P Anderson, KC
Citation: K. Podar et al., Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration, BLOOD, 98(2), 2001, pp. 428-435
Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome andcan be used to optimize therapy
Authors: Rawstron, AC Kennedy, B Evans, PAS Davies, FE Richards, SJ Haynes, AP Russell, NH Hale, G Morgan, GJ Jack, AS Hillmen, P
Citation: Ac. Rawstron et al., Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome andcan be used to optimize therapy, BLOOD, 98(1), 2001, pp. 29-35
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma
Authors: Davies, FE Raje, N Hideshima, T Lentzsch, S Young, G Tai, YT Lin, B Podar, K Gupta, D Chauhan, D Treon, SP Richardson, PG Schlossman, RL Morgan, GJ Muller, GW Stirling, DI Anderson, KC
Citation: Fe. Davies et al., Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma, BLOOD, 98(1), 2001, pp. 210-216
Kaposi's sarcoma-associated herpesvirus gene sequences are detectable at low copy number in primary amyloidosis
Authors: Raje, N Kica, G Chauhan, D Zhang, YN Teoh, G Treon, SP Hideshima, T Deng, JH Gao, SJ Alsina, M Wally, J Davies, FE Tai, YT Pinkus, GS Pinkus, JL Skinner, M Comenzo, RL Anderson, KC
Citation: N. Raje et al., Kaposi's sarcoma-associated herpesvirus gene sequences are detectable at low copy number in primary amyloidosis, AMYLOID, 7(2), 2000, pp. 126-132
Novel therapeutic targets in multiple myeloma
Authors: Davies, FE Anderson, KC
Citation: Fe. Davies et Kc. Anderson, Novel therapeutic targets in multiple myeloma, EUR J HAEMA, 64(6), 2000, pp. 359-367
High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment
Authors: Davies, FE Rollinson, SJ Rawstron, AC Roman, E Richards, S Drayson, M Child, JA Morgan, GJ
Citation: Fe. Davies et al., High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment, J CL ONCOL, 18(15), 2000, pp. 2843-2851
Positive and negative selection to reduce tumour contamination in peripheral blood stem cell harvests
Authors: Davies, FE Rawstron, AC Pratt, G Coupe, R Clarke, D Lubenko, A Short, K Perren, TJ Selby, PJ MacLennan, S Major, K Woodhead, V Robinson, F Child, JA Smith, GM Johnson, PWM Morgan, GJ
Citation: Fe. Davies et al., Positive and negative selection to reduce tumour contamination in peripheral blood stem cell harvests, HEMATOL ONC, 18(3), 2000, pp. 111-120
Ku86 variant expression and function in multiple myeloma cells is associated with increased sensitivity to DNA damage
Authors: Tai, YT Teoh, G Lin, B Davies, FE Chauhan, D Treon, SP Raje, N Hideshima, T Shima, Y Podar, K Anderson, KC
Citation: Yt. Tai et al., Ku86 variant expression and function in multiple myeloma cells is associated with increased sensitivity to DNA damage, J IMMUNOL, 165(11), 2000, pp. 6347-6355
Isolation and characterization of human multiple myeloma cell enriched populations
Authors: Tai, YT Teoh, G Shima, Y Chauhan, D Treon, SP Raje, N Hideshima, T Davies, FE Anderson, KC
Citation: Yt. Tai et al., Isolation and characterization of human multiple myeloma cell enriched populations, J IMMUNOL M, 235(1-2), 2000, pp. 11-19
SHP2 mediates the protective effect of interleukin-6 against dexamethasone-induced apoptosis in multiple myeloma cells
Authors: Chauhan, D Pandey, P Hideshima, T Treon, S Raje, N Davies, FE Shima, Y Tai, YT Rosen, S Avraham, S Kharbanda, S Andersons, KC
Citation: D. Chauhan et al., SHP2 mediates the protective effect of interleukin-6 against dexamethasone-induced apoptosis in multiple myeloma cells, J BIOL CHEM, 275(36), 2000, pp. 27845-27850
Controversies surrounding the clonogenic origin of multiple myeloma
Authors: Davies, FE Rawstron, AC Owen, RG Morgan, GJ
Citation: Fe. Davies et al., Controversies surrounding the clonogenic origin of multiple myeloma, BR J HAEM, 110(1), 2000, pp. 240-241
Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy
Authors: Hideshima, T Chauhan, D Shima, Y Raje, N Davies, FE Tai, YT Treon, SP Lin, B Schlossman, RL Richardson, P Muller, G Stirling, DI Anderson, KC
Citation: T. Hideshima et al., Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy, BLOOD, 96(9), 2000, pp. 2943-2950
The interleukin-6 receptor alpha-chain (CD126) is expressed by neoplastic but not normal plasma cells
Authors: Rawstron, AC Fenton, JAL Ashcroft, J English, A Jones, RA Richards, SJ Pratt, G Owen, R Davies, FE Child, JA Jack, AS Morgan, G
Citation: Ac. Rawstron et al., The interleukin-6 receptor alpha-chain (CD126) is expressed by neoplastic but not normal plasma cells, BLOOD, 96(12), 2000, pp. 3880-3886
FICTION-TSA analysis of the B-cell compartment in myeloma shows no significant expansion of myeloma precursor cells
Authors: Davies, FE Rawstron, AC Pratt, G O'Connor, S Su'ut, L Blythe, D Fenton, J Claydon, D Child, JA Jack, AS Morgan, GJ
Citation: Fe. Davies et al., FICTION-TSA analysis of the B-cell compartment in myeloma shows no significant expansion of myeloma precursor cells, BR J HAEM, 106(1), 1999, pp. 40-46
Liposomal daunorubicin: In vitro and in vivo efficacy in multiple myeloma
Authors: Pratt, G Wiles, ME Rawstron, AC Davies, FE Fenton, JAL Proffitt, JA Child, JA Smith, GM Morgan, GJ
Citation: G. Pratt et al., Liposomal daunorubicin: In vitro and in vivo efficacy in multiple myeloma, HEMATOL ONC, 16(2), 1998, pp. 47-55
True spectrum of 14q32 translocations in multiple myeloma
Authors: Pratt, G Fenton, JAL Proffitt, JA Rawstron, AC Davies, FE Child, JA Morgan, GJ
Citation: G. Pratt et al., True spectrum of 14q32 translocations in multiple myeloma, BR J HAEM, 103(4), 1998, pp. 1209-1210
Risultati: 1-20 |